Itonis, Inc. (ITNS)

USD 0.0

(14.29%)

EBITDA Summary of Itonis, Inc.

  • Itonis, Inc.'s latest annual EBITDA in 2023 was -38.31 Thousand USD , down -362.12% from previous year.
  • Itonis, Inc.'s latest quarterly EBITDA in 2024 Q3 was -664.00 USD , down -5.4% from previous quarter.
  • Itonis, Inc. reported an annual EBITDA of -7573.00 USD in 2022, up 88.13% from previous year.
  • Itonis, Inc. reported an annual EBITDA of -71.38 Thousand USD in 2021, down -45.73% from previous year.
  • Itonis, Inc. reported a quarterly EBITDA of -520.00 USD for 2024 Q1, up 79.2% from previous quarter.
  • Itonis, Inc. reported a quarterly EBITDA of -664.00 USD for 2024 Q3, down -5.4% from previous quarter.

Annual EBITDA Chart of Itonis, Inc. (2023 - 2005)

Created with Highcharts 11.1.0YearsEBITDA200620082010201220142016201820202022-2500000 USD-2000000 USD-1500000 USD-1000000 USD-500000 USD0 USD

Historical Annual EBITDA of Itonis, Inc. (2023 - 2005)

Year EBITDA EBITDA Growth
2023 -38.31 Thousand USD -362.12%
2022 -7573.00 USD 88.13%
2021 -71.38 Thousand USD -45.73%
2020 -47.3 Thousand USD 21.16%
2019 -60.99 Thousand USD 14.79%
2018 -71.32 Thousand USD -14.79%
2017 -62.13 Thousand USD 85.11%
2016 -419.18 Thousand USD 0.0%
2007 -1.28 Million USD 48.38%
2006 -2.31 Million USD -365.62%
2005 -565.01 Thousand USD 0.0%

Peer EBITDA Comparison of Itonis, Inc.

Name EBITDA EBITDA Difference
China Medicine Corporation 13.27 Million USD 100.289%
DH Enchantment Inc. -145.23 Thousand USD 73.621%
Exlites Holdings International, Inc. -90.49 Thousand USD 57.665%
One Step Vending Corp. -26.55 Thousand USD -44.283%
MediPal Holdings Corporation 431.52 Million USD 100.009%
PD-Rx Pharmaceuticals, Inc. -51.41 Thousand USD 25.494%
Pharmagen, Inc. -2.89 Million USD 98.676%
Suzuken Co., Ltd. 340.78 Million USD 100.011%